Pmv Pharmaceuticals, Inc
Clinical trials sponsored by Pmv Pharmaceuticals, Inc, explained in plain language.
-
New drug targets rare cancer mutation in 300-Patient trial
Disease control Recruiting nowThis study tests a new drug called PC14586 (rezatapopt) in people with advanced solid tumors that have a specific TP53 Y220C mutation. The goal is to see if the drug is safe and shrinks tumors. About 300 adults whose cancer has worsened after prior treatment will take the drug al…
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
New cancer Drug's side effects on common meds under microscope
Knowledge-focused Recruiting nowThis early-phase study looks at how a new drug called rezatapopt changes the way the body processes four common medications (metformin, rosuvastatin, repaglinide, and midazolam) in people with advanced solid tumors that have a specific TP53 Y220C mutation. About 14 participants w…
Phase: PHASE1 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC